Search hospitals > New York > Brooklyn
New York Methodist Hospital
Claim this profileBrooklyn, New York 11215
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Prostate Cancer
Conducts research for Lung Cancer
Conducts research for Heart Failure
218 reported clinical trials
14 medical researchers
Summary
New York Methodist Hospital is a medical facility located in Brooklyn, New York. This center is recognized for care of Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Heart Failure and other specialties. New York Methodist Hospital is involved with conducting 218 clinical trials across 299 conditions. There are 14 research doctors associated with this hospital, such as Hani Ashamalla, M.D., Scott Tagawa, MD, Margaux J. Kanis, and Uqba Khan.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
HER2 positive
Top PIs
Hani Ashamalla, M.D.New York-Presbyterian/Brooklyn Methodist Hospital2 years of reported clinical research
Studies Breast Cancer
Studies Cancer
18 reported clinical trials
46 drugs studied
Scott Tagawa, MDWeill Cornell Medical College3 years of reported clinical research
Expert in Prostate Cancer
Studies Kidney Cancer
13 reported clinical trials
23 drugs studied
Margaux J. KanisNew York-Presbyterian/Brooklyn Methodist Hospital4 years of reported clinical research
Studies Adenocarcinoma
Studies Serous Cystadenocarcinoma
3 reported clinical trials
7 drugs studied
Uqba KhanNew York-Presbyterian/Brooklyn Methodist Hospital4 years of reported clinical research
Studies Colorectal Cancer
Studies Adenocarcinoma
4 reported clinical trials
15 drugs studied
Clinical Trials running at New York Methodist Hospital
Breast Cancer
Bladder Carcinoma
Non-Small Cell Lung Cancer
Lung Cancer
Prostate Cancer
Bladder Cancer
Renal Cell Carcinoma
Brain Tumor
Cancer
Oropharyngeal Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Omitting Radiation Therapy
for Breast Cancer
This study is evaluating whether a type of radiation therapy may help prevent breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Accelerated Radiation Therapy
for Breast Cancer
This study is evaluating whether a shorter course of radiation may be as effective as the standard course of radiation for breast cancer.
Recruiting2 awards Phase 31 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at New York Methodist Hospital?
New York Methodist Hospital is a medical facility located in Brooklyn, New York. This center is recognized for care of Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Heart Failure and other specialties. New York Methodist Hospital is involved with conducting 218 clinical trials across 299 conditions. There are 14 research doctors associated with this hospital, such as Hani Ashamalla, M.D., Scott Tagawa, MD, Margaux J. Kanis, and Uqba Khan.